Skip to main content Accessibility help
×
Home
  • Print publication year: 2009
  • Online publication date: August 2010

Part 3 - Sleepdisorders in the elderly

References

1. OhayonMM, CarskadonMA, GuilleminaultC, VitielloMV. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 2004;27(7):1255–73.
2. BrassingtonGS, KingAC, BliwiseDL. Sleep problems as a risk factor for falls in a sample of community-dwelling adults aged 64–99 years. J Am Geriatr Soc 2000;48(10):1234–40.
3. DewMA, HochCC, BuysseDJ, et al. Healthy older adults’ sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med 2003;65:63–73.
4. Ancoli-IsraelS, KripkeDF, KlauberMR, et al. Sleep disordered breathing in community-dwelling elderly. Sleep 1991;14(6):486–95.
5. BliwiseDL, CarskadonMA, CareyE, DementWC. Longitudinal development of sleep-related respiratory disturbance in adult humans. J Gerontol 1984;39:290–3.
6. YoungT, PaltaM, DempseyJ, et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230–5.
7. Ancoli-IsraelS, GehrmanP, KripkeDF, et al. Long-term follow-up of sleep disordered breathing in older adults. Sleep Med 2001;2(6):511–6.
8. HochCC, ReynoldsCFI, MonkTH, et al. Comparison of sleep-disordered breathing among healthy elderly in the seventh, eighth, and ninth decades of life. Sleep 1990;13(6):502–11.
9. YoungT, ShaharE, NietoFJ, et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 2002;162(8):893–900.
10. PhillipsB, Ancoli-IsraelS. Sleep disorders in the elderly. Sleep Med 2001;2(2):99–114.
11. MartinJ, StepnowskyC, Ancoli-IsraelS. Sleep apnea in the elderly. In McNicholasWT, PhillipsonEA, eds. Breathing Disorders During Sleep. London: W.B. Saunders; 2002: pp. 278–87.
12. AloiaMS, IlniczkyN, Di DioP, et al. Neuropsychological changes and treatment compliance in older adults with sleep apnea. J Psychosom Res 2003;54:71–6.
13. RedlineS, StraussME, AdamsN, et al. Neuropsychological function in mild sleep-disordered breathing. Sleep 1997;20(2):160–7.
14. Ancoli-IsraelS. Guest Editorial: Sleep apnea in older adults – is it real and should age be the determining factor in the treatment decision matrix?Sleep Med Rev 2007;11:83–5.
15. Ancoli-IsraelS, KripkeDF, KlauberMR, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991;14(6):496–500.
16. GehrmanPR, StepnowskyC, Cohen-ZionM, et al. Long-term follow-up of periodic limb movements in sleep in older adults. Sleep 2002;25(3):340–6.
17. AllenRP, PicchiettiDL, HeningWA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the Restless Legs Syndrome Diagnosis and Epidemiology Workshop at the National Institutes of Health. Sleep Med 2003;4:101–19.
18. O’KeeffeST, GavinK, LavanJN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200–3.
19. SunER, ChenCA, HoG, EarleyCJ, AllenRP. Iron and the restless legs syndrome. Sleep 1998;21(4):371–7.
20. HornyakM, TrenkwalderC. Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res 2004;56(5):543–8.
21. OhayonMM, RothT. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547–54.
22. SchenckCH, BundlieSR, MahowaldMW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388–93.
23. BoeveBF, SilberMH, FermanTJ, LucasJA, ParisiJE. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16(4):622–30.
24. OlsonEJ, BoeveBF, SilberMH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123:331–9.
25. OhayonMM, CauletM, PriestRG. Violent behavior during sleep. J Clin Psychiatry 1997;58(8):369–76.
26. Stiasny-KolsterK, MayerG, SchaferS, et al. The REM sleep behavior disorder screening questionnaire –a new diagnostic instrument. Mov Disord 2007;22(16):2386–93.
27. VitielloMV. Sleep disorders and aging. Curr Opin Psychiatry 1996;9(4):284–9.
28. EspirituRC, KripkeDF, Ancoli-IsraelS, et al. Low illumination by San Diego adults: association with atypical depressive symptoms. Biol Psychiatry 1994;35:403–7.
29. Ancoli-IsraelS, KlauberMR, JonesDW, et al. Variations in circadian rhythms of activity, sleep and light exposure related to dementia in nursing home patients. Sleep 1997;20(1):18–23.
30. ShochatT, MartinJ, MarlerM, Ancoli-IsraelS. Illumination levels in nursing home patients: effects on sleep and activity rhythms. J Sleep Res 2000;9(4):373–80.
31. JonesCR, CampbellSS, ZoneSE, et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med 1999;5(9):1062–5.
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision: DSM-IV-TR. Washington, D.C.: American Psychiatric Association; 2000.
33. FoleyDJ, MonjanA, SimonsickEM, WallaceRB, BlazerDG. Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6800 persons over three years. Sleep 1999;22(Suppl. 2):S366–72.
34. FoleyDJ, MonjanAA, BrownSL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18(6):425–32.
35. FoleyDJ, Ancoli-IsraelS, BritzP, WalshJ. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56(5):497–502.
36. KlinkME, QuanSF, KaltenbornWT, LebowitzMD. Risk factors associated with complaints of insomnia in a general adult population: influence of previous complaints of insomnia. Arch Intern Med 1992;152(8):1634–7.
37. KatzDA, McHorneyCA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998;158(10):1099–107.
38. WilcoxS, BrenesGA, LevineD, et al. Factors related to sleep disturbance in older adults experiencing knee pain or knee pain with radiographic evidence of knee osteoarthritis. J Am Geriatr Soc 2000;48(10):1241–51.
39. SridharGR, MadhuK. Prevalence of sleep disturbance in diabetes mellitus. Diabetes Res Clin Pract 1994;23(3):183–6.
40. Ancoli-IsraelS, MooreP, JonesV. The relationship between fatigue and sleep in cancer patients: a review. Eur J Cancer Care 2001;10(4):245–55.
41. KlinkM, QuanSF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest 1987;91:540–6.
42. MallonL, BromanJE, HettaJ. Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Int Med 2005;251(3):207–16.
43. SavardJ, MorinCM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19(3):895–908.
44. QuanSF, KatzR, OlsonJ, et al. Factors associated with incidence and persistence of symptoms of disturbed sleep in an elderly cohort: the cardiovascular health study. Am J Med Sci 2005;329(4):163–72.
45. Garcia-BorregueroD, LarrosaO, BravoM. Parkinson’s disease and sleep. Sleep Med Rev 2003;7(2):115–29.
46. FordDE, KamerowDB. Epidemiologic study of sleep disturbances and psychiatric disorders: an opportunity for prevention?JAMA 1989;262(11):1479–84.
47. OhayonMM, RothT. What are the contributing factors for insomnia in the general population?J Psychosom Res 2001;51:745–55.
48. BuysseDJ, ReynoldsCF, KupferDJ, et al. Clinical diagnoses in 216 insomnia patients using the international classification of sleep disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV field trial. Sleep 1994;17(7):630–7.
49. RiemannD, VoderholzerU. Primary insomnia: a risk factor to develop depression?J Affect Disorder 2003;76:255–9.
50. FavaM. Daytime sleepiness and insomnia as correlates of depression. J Clin Psychiatry 2004;65(Suppl. 16):27–32.
51. ColeMG, DendukuriN. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003;160(6):1147–56.
52. PerlisML, SmithLJ, LynessJM, et al. Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006;4(2):104–13.
53. NowellPD, BuysseDJ. Treatment of insomnia in patients with mood disorders. Depress Anxiety 2001;14(1):7–18.
54. Ancoli-IsraelS, RothT. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999;22(Suppl. 2):S347–53.
55. PhillipsB, ManninoDM. Does insomnia kill?Sleep 2005;28(8):965–71.
56. RediehsMH, ReisJS, CreasonNS. Sleep in old age: focus on gender differences. Sleep 1990;13(5):410–24.
57. ZammitGK, WeinerJ, DamatoN, SillupGP, McMillanCA. Quality of life in people with insomnia. Sleep 1999;22(Suppl. 2):S379–85.
58. WalshJK, BencaRM, BonnetM, et al. Insomnia: assessment and management in primary care: National Heart, Lung, and Blood Institute Working Group on Insomnia. Am Fam Physician 1999;59(11):3029–37.
59. CrenshawMC, EdingerJD. Slow-wave sleep and waking cognitive performance among older adults with and without insomnia complaints. Physiol Behav 1999;66(3):485–92.
60. PollakCP, PerlickD, LinsnerJP, WenstonJ, HsiehF. Sleep problems in the community elderly as predictors of death and nursing home placement. J Community Health 1990;15(2):123–35.

References

1. CarrierJ, MonkTH, BuysseDJ, KupferDJ. Sleep and morningness-eveningness in the ‘middle’ years of life (20–59 y). J Sleep Res 1997;6:230–7.
2. DuffyJF, DijkDJ, KlermanEB, CzeislerCA. Later endogenous circadian temperature nadir relative to an earlier wake time in older people. Am J Physiol 1998;275:R1478–87.
3. HorneJA, OstbergO. A self-assessment questionnaire to determine morningness-eveningness in human circadian rhythms. Int J Chronobiol 1976;4:97–110.
4. FoleyDJ, MonjanAA, BrownSL, et al. Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep 1995;18:425–32.
5. CampbellSS, MurphyPJ, van den HeuvelCJ, RobertsML, StaubleTN. Etiology and treatment of intrinsic circadian rhythm disorders. Sleep Med Rev 1999;3(3):179–200.
6. ReidKJ, ZeePC. Circadian rhythm disorders. Semin Neurol 2004;24(3):315–25.
7. American Academy of Sleep Medicine. The International Classification of Sleep Disorders: Diagnostic & Coding Manual, 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
8. CampbellSS. Duration and placement of sleep in a “disentrained” environment. Psychophysiology 1984;21(1):106–13.
9. JacobsD, Ancoli-IsraelS, ParkerL, KripkeDF. Twenty-four-hour sleep-wake patterns in a nursing home population. Psychol Aging 1989;4:352–6.
10. BuysseDJ, ReynoldsCF 3rd, KupferDJ, et al. Clinical diagnoses in 216 insomnia patients using the International Classification of Sleep Disorders (ICSD), DSM-IV and ICD-10 categories: a report from the APA/NIMH DSM-IV Field Trial. Sleep 1994;17:630–7.
11. KameiR, HughesL, MilesL, DementW. Advanced sleep phase syndrome studied in a time isolation facility. Chronobiologia 1979;6:115.
12. MoldofskyH, MusisiS, PhillipsonEA. Treatment of a case of advanced sleep phase syndrome by phase advance chronotherapy. Sleep 1986;9:61–5.
13. SchraderH, BovimG, SandT. The prevalence of delayed and advanced sleep phase syndromes. J Sleep Res 1993;2:51–5.
14. DaganY, EisensteinM. Circadian rhythm sleep disorders: toward a more precise definition and diagnosis. Chronobiol Int 1999;16:213–22.
15. LowreyPL, TakahashiJS. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Gen 2004;5:407–41.
16. GachonF, NagoshiE, BrownSA, RippergerJ, SchiblerU. The mammalian circadian timing system: from gene expression to physiology. Chromosoma 2004;113(3):103–12.
17. CzeislerCA, DuffyJF, ShanahanTL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999;284(5423):2177–81.
18. PittendrighCS, DaanS. A functional analysis of circadian pacemakers in nocturnal rodents: IV. Entrainment: pacemaker as clock. J Comp Physiol [A] 1976;106:291–331.
19. VirshupDM, ForgerDB. After hours keeps clock researchers CRYing Overtime. Cell 2007;129:857–9.
20. DijkDJ, LockleySW. Integration of human sleep-wake regulation and circadian rhythmicity. J Appl Physiol 2002;92(2):852–62.
21. TohKL, JonesCR, HeY, et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001;291(5506):1040–3.
22. DijkDJ, DuffyJF, CzeislerCA. Contribution of circadian physiology and sleep homeostasis to age-related changes in human sleep. Chronobiol Int 2000;17:285–311.
23. ZavadaA, GordijnMC, BeersmaDG, DaanS, RoennebergT. Comparison of the Munich Chronotype Questionnaire with the Horne-Ostberg’s Morningness-Eveningness Score. Chronobiol Int 2005;22:267–78.
24. LewyAJ, EmensJ, JackmanA, YuhasK. Circadian uses of melatonin in humans. Chronobiol Int 2006;23:403–12.
25. BenloucifS, BurgessHJ, KlermanEB, et al. Measuring melatonin in humans. J Clin Sleep Med 2008;4:66–9.
26. DuffyJF, DijkDJ. Getting through to circadian oscillators: why use constant routines?J Biol Rhythms 2002;17:4–13.
27. KlermanEB, DijkDJ, KronauerRE, CzeislerCA. Simulations of light effects on the human circadian pacemaker: implications for assessment of intrinsic period. Am J Physiol 1996;270:R271–82.
28. RalphMR, MenakerM. A mutation of the circadian system in golden hamsters. Science 1988;241:1225–7.
29. LowreyPL, ShimomuraK, AntochMP, et al. Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau. Science 2000;288(5465):483–91.
30. GallegoM, EideEJ, WoolfMF, VirshupDM, ForgerDB. An opposite role for tau in circadian rhythms revealed by mathematical modeling. Proc Natl Acad Sci USA 2006;103:10618–23.
31. MengQJ, LogunovaL, MaywoodES, et al. Setting clock speed in mammals: the CK1 epsilon tau mutation in mice accelerates circadian pacemakers by selectively destabilizing PERIOD proteins. Neuron 2008;58:78–88.
32. DrennanMD, SelbyJ, KripkeDF, KelsoeJ, GillinJC. Morningness/eveningness is heritable. Soc Neurosci Abstr 1992;18:196.
33. VinkJM, GrootAS, KerkhofGA, BoomsmaDI. Genetic analysis of morningness and eveningness. Chronobiol Int 2001;18(5):809–22.
34. EbisawaT. Circadian rhythms in the CNS and peripheral clock disorders: human sleep disorders and clock genes. J Pharmacol Sci 2007;103:150–4.
35. JonesCR, CampbellSS, ZoneSE, et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med 1999;5(9):1062–5.
36. VanselowK, VanselowJT, WestermarkPO, et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS). Genes Dev 2006;20:2660–72.
37. XuY, TohKL, JonesCR, et al. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 2007;128:59–70.
38. ReidKJ, ChangAM, DubocovichML, et al. Familial advanced sleep phase syndrome. Arch Neurol 2001;58(7):1089–94.
39. SatohK, MishimaK, InoueY, EbisawaT, ShimizuT. Two pedigrees of familial advanced sleep phase syndrome in Japan. Sleep 2003;26(4):416–7.
40. XuY, PadiathQS, ShapiroRE, et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005;434(7033):640–4.
41. WeinertD. Age-dependent changes of the circadian system. Chronobiol Int 2000;17:261–83.
42. DijkDJ, von SchantzM. Timing and consolidation of human sleep, wakefulness, and performance by a symphony of oscillators. J Biol Rhythms 2005;20:279–90.
43. PittendrighCS, DaanS. Circadian oscillations in rodents: a systematic increase of their frequency with age. Science 1974;186:548–50.
44. MorinLP. Age-related changes in hamster circadian period, entrainment, and rhythm splitting. J Biol Rhythms 1988;3:237–48.
45. DavisFC, ViswanathanN. Stability of circadian timing with age in Syrian hamsters. Am J Physiol 1998;44:R960–R8.
46. DuffyJF, ViswanathanN, DavisFC. Free-running circadian period does not shorten with age in female Syrian hamsters. Neurosci Lett 1999;271:77–80.
47. KendallAR, LewyAJ, SackRL. Effects of aging on the intrinsic circadian period of totally blind humans. J Biol Rhythms 2001;16:87–95.
48. DuffyJF, CzeislerCA. Age-related change in the relationship between circadian period, circadian phase, and diurnal preference in humans. Neurosci Lett 2002;318:117–20.
49. Van CoevordenA, MockelJ, LaurentE, et al. Neuroendocrine rhythms and sleep in aging men. Am J Physiol Endocrinol Metab 1991;260:E651–E61.
50. Van CauterE, LeproultR, KupferDJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 1996;81:2468–73.
51. DuffyJF, DijkDJ, HallEF, CzeislerCA. Relationship of endogenous circadian melatonin and temperature rhythms to self-reported preference for morning or evening activity in young and older people. J Investig Med 1999;47(3):141–50.
52. DuffyJF, ZeitzerJM, RimmerDW, et al. Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. Am J Physiol Endocrinol Metab 2002;282(2):E297–E303.
53. DijkDJ, DuffyJF, CzeislerCA. Age-related increase in awakenings: impaired consolidation of nonREM sleep at all circadian phases. Sleep 2001;24:565–77.
54. KlermanEB, DavisJB, DuffyJF, DijkDJ, KronauerRE. Older people awaken more frequently but fall back asleep at the same rate as younger people. Sleep 2004;27:793–8.
55. DijkDJ, DuffyJF, RielE, ShanahanTL, CzeislerCA. Ageing and the circadian and homeostatic regulation of human sleep during forced desynchrony of rest, melatonin and temperature rhythms. J Physiol 1999;516(Pt 2):611–27.
56. SwaabDF, FliersE, PartimanTS. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985;342(1):37–44.
57. HofmanMA, SwaabDF. Living by the clock: the circadian pacemaker in older people. Ageing Res Rev 2006;5:33–51.
58. CampbellSS, KripkeDF, GillinJC, HrubovcakJC. Exposure to light in healthy elderly subjects and Alzheimer’s patients. Physiol Behav 1988;42:141–4.
59. KawinskaA, DumontM, SelmaouiB, PaquetJ, CarrierJ. Are modifications of melatonin circadian rhythm in the middle years of life related to habitual patterns of light exposure?J Biol Rhythms 2005;20:451–60.
60. YoungstedtSD, KripkeDF, ElliottJA, BaehrW, SepulvedaRS. Light exposure, sleep quality, and depression in older adults. In JungEG, Holick MF, eds. Biological Effects of Light. Boston: Kluwer Academic; 1998. pp. 427–35.
61. YoonIY, KripkeDF, YoungstedtSD, ElliottJA. Actigraphy suggests age-related differences in napping and nocturnal sleep. J Sleep Res 2003;12:87–93.
62. BuxtonOM, L’Hermite-BaleriauxM, TurekFW, van CauterE. Daytime naps in darkness phase shift the human circadian rhythms of melatonin and thyrotropin secretion. Am J Physiol Regul Integr Comp Physiol 2000;278:R373–82.
63. KlermanEB, DuffyJF, DijkDJ, CzeislerCA. Circadian phase resetting in older people by ocular bright light exposure. J Investig Med 2001;49:30–40.
64. BenloucifS, GreenK, L’Hermite-BaleriauxM, et al. Responsiveness of the aging circadian clock to light. Neurobiol Aging 2006;27:1870–9.
65. KripkeDF, ElliottJA, YoungstedtSD, RexKM. Circadian phase response curves to light in older and young women and men. J Circadian Rhythms 2007;5:4.
66. BoivinDB, DuffyJF, KronauerRE, CzeislerCA. Dose-response relationships for resetting of human circadian clock by light. Nature 1996;379:540–2.
67. DuffyJF, ZeitzerJM, CzeislerCA. Decreased sensitivity to phase-delaying effects of moderate intensity light in older subjects. Neurobiol Aging 2007;28:799–807.
68. SackRL, AuckleyD, AugerRR, et al. Circadian rhythm sleep disorders: part II, advanced sleep phase disorder, delayed sleep phase disorder, free-running disorder, and irregular sleep-wake rhythm. Sleep 2007;30:1484–501.
69. MorgenthalerTI, KapurVK, BrownT, et al. Practice parameters for the treatment of narcolepsy and other hypersomnias of central origin. Sleep 2007;30:1705–11.
70. LewyAJ, AhmedS, JacksonJM, SackRL. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992;9:380–92.
71. BersonDM. Strange vision: ganglion cells as circadian photoreceptors. Trends Neurosci 2003;26(6):314–20.
72. SuhnerAG, MurphyPJ, CampbellSS. Failure of timed bright light exposure to alleviate age-related sleep maintenance insomnia. J Am Geriatr Soc 2002;50:617–23.
73. LackL, WrightH. The effect of evening bright light in delaying the circadian rhythms and lengthening the sleep of early morning awakening insomniacs. Sleep 1993;16:436–43.
74. CampbellS, DawsonD, AndersonM. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatric Soc 1993;41:829–36.
75. PalmerCR, KripkeDF, SavageHC Jr., et al. Efficacy of enhanced evening light for advanced sleep phase syndrome. Behav Sleep Med 2003;1:213–26.
76. PallesenS, NordhusIH, SkeltonSH, BjorvatnB, SkjerveA. Bright light treatment has limited effect in subjects over 55 years with mild early morning awakening. Percept Mot Skills 2005;101:759–70.
77. LackL, WrightH, KempK, GibbonS. The treatment of early-morning awakening insomnia with 2 evenings of bright light. Sleep 2005;28:616–23.

References

1. MonkTH. Aging human circadian rhythms: conventional wisdom may not always be right. J Biol Rhythms 2005;20(4):366–74.
2. KnauthP, KiesswetterE, OttmannW, KarvonenMJ, RutenfranzJ. Time-budget studies of policemen in weekly or swiftly rotating shift systems. Appl Ergonom 1983;14.4:247–52.
3. ForetJ, BensimonG, BenoitO, et al. Quality of sleep as a function of age and shift work: In ReinbergA, VieuxN, AndlauerP, eds. Night and Shift Work: Biological and Social Aspects. Oxford: Pergamon Press; 1981; pp. 149–60.
4. BrugereD, BarritJ, ButatC, CossetM, VolkoffS. Shiftwork, age, and health: an epidemiologic investigation. Int J Occup Environ Health 1997;3(Suppl. 2): S15–19.
5. HarmaM, HakolaT, AkerstedtT, LaitinenJ. Age and adjustment to night work. Occup Environ Med 1994;51:568–73.
6. PrestonFS. Further sleep problems in airline pilots on world-wide schedules. Aerosp Med 1973;44(7):775–82.
7. GanderPH, NguyenD, RosekindMR, ConnellLJ. Age, circadian rhythms, and sleep loss in flight crews. Aviat Space Environ Med 1993;64(3 Pt 1):189–95.
8. MonkTH, BuysseDJ, ReynoldsCF, KupferDJ. Inducing jet lag in older people: adjusting to a 6-hour phase advance in routine. Exp Gerontol 1993;28(2):119–33.
9. MonkTH, BuysseDJ, CarrierJ, KupferDJ. Inducing jet-lag in older people: directional asymmetry. J Sleep Res 2000;9:101–16.
10. KlermanEB, DuffyJF, DijkDJ, CzeislerCA. Circadian phase resetting in older people by ocular bright light exposure. J Investig Med 2001;49(1):30–40.
11. MonkTH, MolineML, GraeberRC. Inducing jet lag in the laboratory: patterns of adjustment to an acute shift in routine. Aviat Space Environ Med 1988;59(8):703–10.
12. MolineML, PollakCP, MonkTH, et al. Age-related differences in recovery from simulated jet lag. Sleep 1992;15(1):28–40.
13. CarrierJ, MonkTH, BuysseDJ, KupferDJ. Sleep and morningness-eveningness in the “middle” years of life (20–59y). J Sleep Res 1997;6:230–7.
14. CzeislerCA, DumontM, DuffyJF, et al. Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet 1992;340:933–6.
15. YoonIY, KripkeDF, YoungstedtSD, ElliottJA. Actigraphy suggests age-related differences in napping and nocturnal sleep. J Sleep Res 2003;12(2):87–93.
16. MonkTH, KupferDJ. Circadian rhythms in healthy aging: effects downstream from the pacemaker. Chronobiol Int 2000;17(3):355–68.
17. BuysseDJ, MonkTH, CarrierJ, BegleyA. Circadian patterns of sleep, sleepiness, and performance in older and younger adults. Sleep 2005;28(11):1365–76.
18. CostaG. Shift work and occupational medicine: an overview. Occup Med (Lond) 2003;53(2):83–8.
19. KnutssonA. Health disorders of shift workers. Occup Med (Lond) 2003;53(2):103–8.
20. ScottAJ. Shift work and health. Prim Care 2000;27(4):1057–79.
21. ICSD Diagnostic Classification Steering Committee. International Classification of Sleep Disorders: Diagnostic and Coding Manual. Rochester, MN: American Sleep Disorders Association; 1990.
22. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, D.C.: American Psychiatric Association; 1994.
23. KnutssonA, AkerstedtT, Orth-GomerK, JonssonBG. Increased risk of ischaemic heart disease in shift workers. Lancet 1986;2(8498):89–92.
24. SchernhammerES, LadenF, SpeizerFE, et al. Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 2001;93(20):1563–8.
25. MegdalSP, KroenkeCH, LadenF, PukkalaE, SchernhammerES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 2005;41(13):2023–32.
26. SchwartzbaumJ, AhlbomA, FeychtingM. Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 2007;33(5):336–43.
27. GordonNP, ClearyPD, ParkerCE, CzeislerCA. The prevalence and health impact of shiftwork. Am J Public Health 1986;76:1225–8.
28. ScottAJ, MonkTH, BrinkL. Shiftwork as a risk factor for depression: a pilot study. Int J Occup Environ Health 1997;3(3):S2–S9.
29. KupferDJ, MonkTH, BarchasJD, et al., eds. Biological Rhythms and Mental Disorders. New York: The Guilford Press; 1988.
30. SpiegelK, KnutsonK, LeproultR, TasaliE, Van CauterE. Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005;99(5):2008–19.
31. van AmelsvoortLG, SchoutenEG, KokFJ. Duration of shiftwork related to body mass index and waist to hip ratio. Int J Obes Relat Metab Disord 1999;23(9):973–8.
32. KarlssonB, KnutssonA, LindahlB. Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27485 people. Occup Environ Med 2001;58(11):747–52.
33. NagayaT, YoshidaH, TakahashiH, KawaiM. Markers of insulin resistance in day and shift workers aged 30–59 years. Int Arch Occup Environ Health 2002;75(8):562–8.
34. WalkerJM. Social problems of shift work. In FolkardS, MonkTH, eds. Hours of Work: Temporal Factors in Work Scheduling. New York: John Wiley & Sons; 1985; pp. 211–25.
35. ColliganMJ, RosaRR. Shiftwork effects on social and family life. Occup Med 1990;5:315–22.

References

1. TikkinenKA, TammelaTL, HuhtalaH, et al. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006;175:596–600.
2. SchatzlG, TemmlC, SchmidbauerJ, et al. Cross-sectional study of nocturia in both sexes: analysis of a voluntary health screening project. Urology 2000;56:71–5.
3. AsplundR. Nocturia in the elderly in relation to thirst, dry mouth and dry eyes. Can J Urol 2004;11:1749–53.
4. WeissJP, BlaivasJG, JonesM, et al. Age related pathogenesis of nocturia in patients with overactive bladder. J Urol 2007;178:548–51.
5. CoyneK-S, ZhouZ, BhattacharyyaS-K, et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int 2003;92:948–54.
6. BlandyJ. Nocturia may be due to growing old. Br Med J 1996;312:1228–9.
7. FitzgeraldMP, LitmanHJ, LinkCL, et al. The association of nocturia with cardiac disease, diabetes, body mass index, age and diuretic use: results from the BACH survey. J Urol 2007;177:1385–9.
8. AsplundR. Mortality in the elderly in relation to nocturnal micturition. BJU Int 1999;84:297–301.
9. AsplundR. Micturition habits and diuresis in relation to sleep and well-being in elderly subjects with emphasis on antidiuretic hormone. (Thesis) Stockholm 1992.
10. AsplundR. Nocturia, nocturnal polyuria, and sleep quality in the elderly. J Psychosom Res 2004;56:517–25.
11. van KerrebroeckP, AbramsP, ChaikinD, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:179–83.
12. BingMH, MollerLA, JennumP, et al. Pathophysiological aspects of nocturia in a Danish population of men and women age 60 to 80 years. J Urol 2007;178:552–7.
13. AsplundR. Hip fractures, nocturia and nocturnal polyuria in the elderly. Arch Gerontol Geriatr 2006;43:319–26.
14. StewartRB, MooreMT, MayFE, et al. Nocturia: a risk factor for falls in the elderly. J Am Geriatr Soc 1992;40:1217–20.
15. NevalainenTH, HiltunenLA, JalovaaraP. Functional ability after hip fracture among patients home-dwelling at the time of fracture. Cent Eur J Public Health 2004;12:211–6.
16. FierensJ, BroosPL. Quality of life after hip fracture surgery in the elderly. Acta Chir Belg 2006;106:393–6.
17. PiscitelliP, IolasconG, GimiglianoF, et al. Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey. Osteoporos Int 2007;18:211–9.
18. AsplundR. Sleep, health and visual impairment in the elderly. Arch Gerontol Geriatr 2000;30:7–15.
19. AsplundR. Visual impairment, sleep and nocturia in the elderly. Arch Gerontol Geriatr 2005;4:61–7.
20. EhlenzK. Regulation of blood volume: implications for cardiovascular pathophysiology in sleep apnoea. J Sleep Res 1995;4:30–3.
21. KielyJL, MurphyM, McNicholasWT. Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study. Eur Respir J 1999;13:1086–90.
22. ScheinOD, HochbergMC, MuñozB, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999;159:1359–63.
23. PriceEJ, VenablesPJ. Dry eyes and mouth syndrome: a subgroup of patients presenting with sicca symptoms. Rheumatology (Oxford) 2002;41:416–22.
24. GrushkaM, EpsteinJB, GorskyM. Burning mouth syndrome. Am Fam Physician 2002;65:615–20.
25. AsplundR. Sleep, nocturia and the burning mouth syndrome (BMS) in the elderly. Sleep Hypnosis 2006;8:7–12.
26. BergdahlM, BergdahlJ. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med 1999;28:350–4.
27. AsplundR. Obesity in elderly people with nocturia: cause or consequence?Can J Urol 2007;14:3424–8.
28. TikkinenKA, AuvinenA, HuhtalaH, et al. Nocturia and obesity: a population-based study in Finland. Am J Epidemiol 2006;163:1003–11.
29. SchüsslerP, UhrM, IsingM, et al. Nocturnal ghrelin, ACTH, GH and cortisol secretion after sleep deprivation in humans. Psychoneuroendocrinology 2006;31:915–23.
30. van der VaartCH, RooversJP, de LeeuwJR, et al. Association between urogenital symptoms and depression in community-dwelling women aged 20 to 70 years. Urology 2007;69:691–6.
31. BechP, RasmussenNA, OlsenLR, et al. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001;66:159–64.
32. AsplundR, HenrikssonS, JohanssonS, IsacssonG. Nocturia and depression. BJU Int 2004;93:1253–6.
33. ArnaudMJ. Mild dehydration: a risk factor of constipation?Eur J Clin Nutr 2003;57(Suppl. 2):S88–95.
34. AsplundR, ÅbergH. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Int Med 1991;229:131–4.
35. AsplundR, ÅbergH. Diurnal rhythm of antidiuretic hormone in elderly subjects with nocturia. Med Sci Res 1991;19:765–6.
36. AsplundR, ÅbergH. Desmopressin in elderly subjects with increased nocturnal diuresis: a two-month treatment study. Scand J Urol Nephrol 1993;27:77–82.
37. KuoHC. Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years. Urology 2002;59:485–9.
38. LoseG, MattiassonA, WalterS, et al. Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol 2004;172:1021–5.
39. AsplundR. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly. BJU Int 2003;91:302–3.
40. ReynardJM, CannonA, YangQ, et al. A novel therapy for nocturnal polyuria: a double-blind randomized trial of frusemide against placebo. Br J Urol 1998;81:215–8.
41. PedersenPA, JohansenPB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol 1988;62:14–7.
42. AbramsP, AnderssonKE. Muscarinic receptor antagonists for overactive bladder. BJU Int 2007;100:987–1006.
43. KayG, PollackBG, RomanziLJ. Unmasking anticholinergic load: when 1+1=3. CNS Spectr 2004;Suppl. 15:1–11.
44. GuayDR. Clinical pharmacokinetics of drugs used to treat urge incontinence. Clin Pharmacokinet 2003;42:1243–85.
45. AbramsP. Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO). Eur Urol 2005;Suppl. 3:8–16.
46. SaadF, NickelJC, ValiquetteL, et al. Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin. Can J Urol 2005;12:2745–54.
47. JohnsonTM 2nd, JonesK, WillifordWO, et al. Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial. J Urol 2003;170:145–8.
48. CardozoL, RobinsonD. Special considerations in premenopausal and post-menopausal women with symptoms of overactive bladder. Urology 2002;60(Suppl. 1):64–71.
49. MoehrerB, HextallA, JacksonS. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003;(2):CD001405.
50. SwansonSG, DrosmanS, HelmondFA, et al. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study. Menopause 2006;13:917–25.

References

1. NeubauerDN. Sleep problems in the elderly. Am Fam Physician 1999;59:2551–60.
2. SmytheHA, MoldofskyH. Two contributions to understanding of the fibrositis syndrome. Bull Rheum Dis 1977–1978;28:928–31.
3. WolfeF, SmytheHA, YunusMB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–72.
4. WallaceDJ. The history of fibromyalgia. In WallaceDJ, ClauwDJ, eds. Fibromyalgia and Other Central Pain Syndromes. Philadelphia: Lippincott, Williams & Wilkins; 2005: pp. 1–8.
5. YunusM, MasiAT, CalabroJJ, et al. Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Sem Arthritis Rheum 1981;11:151–70.
6. WolfeF, RossK, AndersonJ, RussellIJ, HebertL. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38(1):19–28
7. WhiteK, SpeechleyM, HarthM, et al. The London Fibromyalgia Study: the prevalence of fibromyalgia syndrome (FMS) in London, Ontario. J Rheumatol 1999;26:1570–6.
8. GowinK, GrissoJ, SchumacherH, et al. The Characteristics of Fibromyalgia in Older Persons. Masters thesis. University of Pennsylvania School of Medicine; 1999.
9. RussellIJ. Neurotransmitters, cytokines, hormones and the immune system in chronic nonneuropathic pain. In WallaceDJ, ClauwDJ, eds. Fibromyalgia and Other Central Pain Syndromes. Philadelphia: Lippincott, Williams & Wilkins; 2005: pp. 63–80.
10. StaudR, VierckCJ, CannonRL, et al. Abnormal sensitization and temporal summation of second pain (wind up) in patients with fibromyalgia syndrome. Pain 2001;91:165–75.
11. StaudR. The neurobiology of chronic musculoskeletal pain. In WallaceDJ, ClauwDJ, eds. Fibromyalgia and Other Central Pain Syndromes. Philadelphia: Lippincott, Williams & Wilkins; 2005: pp. 45–62.
12. RussellIG, OrrMD, LittmanB, et al. Elevated cerebrospinal fluid levels of substance P in patients with fibromyalgia syndrome. Arthritis Rheum 1994;37:1593–601.
13. OhayonMM. Prevalence and correlates of nonrestorative sleep complaints. Arch Intern Med 2005;165:35–41.
14. RoizenblattS, MoldofskyH, Benedito-SilvaAA, TufikS. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001;44:222–30.
15. LandisCA, LentzMJ, RothermelJ, BuchwaldD, ShaverJL. Decreased sleep spindles and spindle activity in midlife women with fibromyalgia and pain. Sleep 2004;27:741–50.
16. BaggeE, BengstssonBA, CarlssonL, CarlssonJ. Low growth hormone secretion in patients with fibromyalgia: a preliminary report on 10 patients and 10 controls. J Rheumatol 1998;25:145–8.
17. MoldofskyH, TullisC, LueFA. Sleep related myoclonus in rheumatic pain modulation disorder (Fibrositis syndrome). J Rheumatol 1986;13:614–17.
18. Bara-JimenezW, AksuM, GrahamB, et al. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000;54:1609–16.
19. WallaceDJ. The fibromyalgia syndrome. Ann Med 1997;29:9–21.
20. YunusMB. The concept of central sensitivity syndromes. In WallaceDJ, ClauwDJ, eds. Fibromyalgia and Other Central Pain Syndromes. Philadelphia: Lippincott, Williams & Wilkins; 2005: pp. 29–44.
21. HalleguaDS, WallaceDJ. Managing fibromyalgia: a comprehensive approach. J Musculoskelet Med 2005;22:382–90.
22. GowinKM. Diffuse pain syndromes in the elderly. Rheum Dis Clin North Am 2000;26(3):673–82.
23. ChenLX, BaqirM, SchumacherHR, et al. Increased incidence of sleep apnea in fibromyalgia patients. Arthritis Rheum 2004;50:S494 (abstract).
24. Bou-HolaigahI, CalkinsH, FlynnJA, et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exper Rheumatol 1997;15:230–46.
25. PimentelM, ChowEJ, HalleguaDJ, WallaceDJ, LinHC. Small intestinal bacterial overgrowth: a possible association with fibromyalgia. J Musculoskelet Pain 2001;9(3):107–13.
26. JainAK, CarruthersBM, van de SandeMI, et al. Fibromyalgia syndrome: Canadian clinical working case definition, diagnostic and treatment protocols: a consensus document. J Musculoskelet Pain 2003;11(4):3–76.
27. YunusMB, HoltGS, MasiAT, AldagJC. Fibromyalgia syndrome among the elderly: comparison with younger patients. J Am Geriatr Soc 1988;36(11):987–95.
28. WallaceDJ, ClauwDJ, HalleguaDS. Addressing behavioral problems in fibromyalgia. J Musculoskelet Med 2005;22:562–79.
29. WallaceDJ, ClauwDJ. Fibromyalgia and Other Central Pain Syndromes. Philadelphia: Lippincott, Williams & Wilkins; 2005.
30. ClauwDJ, CroffordLJ. Chronic widespread pain: what we know and what we need to know. Best Prac Res Clin Rheumatol 2003;17:685–701.
31. MoldofskyH, MacFarlaneJG. Sleep and its potential role in chronic pain and fatigue. In WallaceDJ, ClauwDJ, eds. Fibromyalgia and Other Central Pain Syndromes. Philadelphia: Lippincott, Williams & Wilkins; 2005:115–24.
32. MoldofskyH, LueFA, MouslyC, et al. The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996;23:529–33.
33. GoldenbergD, MayiskiyM, MosseyC, et al. A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia. Arthritis Rheum 1996;39:1852–9.
34. GoldenbergDL, FelsonDT, DinermanH. A randomized controlled trial of amitryptiline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986;29:1371–7.
35. ReynoldsWJ, MoldofskyH, SaskinP, LueFA. The effects of cyclobenzaprine on sleep physiology and symptoms in patients with fibromyalgia. J Rheumatol 1991;18:452–4.
36. CarusoI, Sarzi PuttiniP, CazzolaM, et al. Double blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. J Int Med Res 1990;18:201–9.
37. CiteraG, AriasMA, Maldonado-CoccoJA, et al. The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000;19:9–13.
38. HaanenHC, HoenderdosHT, van RommundeRK, et al. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 1991;18:72–5.
39. McCainGA, BellDA, MaiFM, HallidayPD. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988;31:1135–41.
40. DeluzeC, BosiaL, ZirbsA, et al. Electroacupuncture in fibromyalgia: results of a controlled trial. Brit Med J 1992;305:1249–52.
41. KaplanKH, GoldenbergDL, Galvin-NadeauM. The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry 1993;15:284–9.
42. EdingerJD, WohlgemuthWK, KrystalAD, et al. Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 2005;165:2527–35.
43. BennettRM, JonesJ, TurkDC, RussellIJ, MatallanaL. An internet survey of 2596 people with fibromyalgia. BMC Musculoskelet Disord 2007;8:27;1–11.

References

1. HadjistavropoulosT, HerrK, TurkDC, et al. An interdisciplinary expert consensus statement on assessment of pain in older persons. Clin J Pain 2007;23(Suppl. 1):S1–43.
2. American Geriatrics Society Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002;50(Suppl. 6):S205–24.
3. American Geriatrics Society Panel on Chronic Pain in Older Persons. The management of chronic pain in older persons. J Am Geriatr Soc 1998;546(5):635–51.
4. American Medical Directors Association. Pain Management in the Long-term Care Setting: Clinical Practice Guideline (Revised Ed.). Columbia, MD: AMDA; 2003.
5. Australian Pain Society. Pain in Residential Aged Care Facilities: Management Strategies. North Sydney, Australia: Australian Pain Society; 2005.
6. Joint Commission on Accreditation of Healthcare Organizations. Pain Assessment and Management: An Organizational Approach. Oakbrook Terrace, IL: JCAHO; 2000.
7. MerskeyH, BogdukN. Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd ed. Seattle: IASP Press; 1994.
8. EngelGL. The need for a new medical model: a challenge for biomedicine. Science 1977;196:129–36.
9. SmithGT, BeersD. Pain. In MD Feldman, JF Christensen, eds. Behavioral Medicine in Primary Care: A Practical Guide. New York, NY: Lange/McGraw-Hill: 2003: pp. 312–20.
10. TurkDC, MonarchES. Biopsychosocial perspective on chronic pain. In DC Turk, RJ Gatchel, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook, 2nd ed. New York, NY: Guilford Press; 2002: pp. 3–29.
11. BarkinRL, BarkinSJ, BarkinDS. Pharmacotherapeutic management of pain with a focus directed at the geriatric patient. Rheum Dis Clin N Am 2007;33:1–31.
12. Wisconsin Medical Society. Guidelines for the assessment and management of chronic pain. WMJ 2004;103:15–43.
13. HelmeRD, GibsonSJ. The epidemiology of pain in elderly people. Clin Geriatr Med 2001;17(3):417–31.
14. FoxPL, RainaP, JadadAR. Prevalence and treatment of pain in older adults in nursing homes and other long-term care institutions: a systematic review. CMAJ 1999;160:329–33.
15. OhayonMM. Relationship between chronic painful physical condition and insomnia. J Psychiatric Res 2005;39:151–9.
16. PowerJD, PerruccioAV, BadleyEM. Pain as a mediator of sleep problems in arthritis and other chronic conditions. Arthritis Rheum 2005;53(6):911–19.
17. SuttonDA, MoldofskyH, BadleyEM. Insomnia and health problems in Canadians. Sleep 2001;24(6):665–70.
18. FoleyDJ, VitielloMV, BliwiseDL, et al. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation ‘2003 Sleep in America’ Poll. Am J Geriatr Psychiatry 2007;15(4):344–50.
19. FoleyD, Ancoli-IsraelS, BritzP, WalshJ. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res 2004;56(5):497–502.
20. GironMS, ForsellY, BernstenC, et al. Sleep problems in a very old population: drug use and clinical correlates. J Gerontol A Biol Sci Med Sci 2002;57(4):M236–40.
21. JordanJJ, BernardSL, CallahanLF, et al. Self-reported arthritis-related disruptions in sleep and daily life and the use of medical, complementary, and self-care strategies for arthritis: The National Survey of Self-care and Aging. Arch Fam Med 2000;9:143–9.
22. BlaySL, AndreoliSB, GastalFL. Chronic painful physical conditions, disturbed sleep and psychiatric morbidity: results from an elderly survey. Ann Clin Psychiatry 2007;19(3):169–74.
23. LeongIY, FarrellMJ, HelmeRD, GibsonSJ. The relationship between medical comorbidity and self-rated pain, mood disturbance, and function in older people with chronic pain. J Gerontol A Biol Sci Med Sci 2007;62(5):550–5.
24. RudyTE, WeinerDK, LieberSJ, SlabodaJ, BostonJR. The impact of chronic low back pain on older adults: a comparative study of patients and controls. Pain 2007;131(3):293–301.
25. MoldofskyH, ScarisbrickP. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38(1):35–44.
26. HaackM, MullingtonJM. Sustained sleep restriction reduces emotional and physical well-being. Pain 2005;119(1–3):56–64.
27. LentzMJ, LandisCA, RothermelJ, ShaverJL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999;26(7):1586–92.
28. OlderSA, BattafaranoDF, DanningCL, et al. The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor I. J Rheumatol 1998;25(6):1180–6.
29. AffleckG, UrrowsS, TennenH, HigginsP, AbelesM. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain 1996;68:363–8.
30. KundermannB, LautenbacherS. Effects of impaired sleep quality and sleep deprivation on diurnal pain perception. In LavigneG, SessleBJ, ChoiniereM, SojaPJ, eds. Sleep and Pain. Seattle: IASP Press; 2007: pp. 317–52.
31. RoehrsT, RothT. Sleep and pain: interaction of two vital functions. Semin Neurol 2005:25(1):106–16.
32. SmithMT, HaythornthwaiteJA. How do sleep disturbance and chronic pain inter-relate: insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004;8:119–32.
33. GurejeO, Von KorffM, KolaL, et al. The relation between multiple pains and mental disorders: results from the World Mental Health Surveys. Pain 2008;135(1–2):82–91.
34. BairMJ, RobinsonRL, KatonW, KroenkeK. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163(20):2433–45.
35. WilcoxS, BrenesGA, LevineD, et al. Factors related to sleep disturbance in older adults experiencing knee pain or with radiographic evidence of known osteoarthritis. J Am Geriatr Soc 2000;48(10):1241–51.
36. ScuddsRJ, RobertsonJM. Pain factors associated with physical disability in a sample of community-dwelling senior citizens. J Gerontol A Biol Sci Med Sci 2000;55(7):M393–9.
37. AparasuRR, MortJR, BrandtH. Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000. Res Social Adm Pharm 2005;1(3):446–59.
38. DominickKL, AhernFM, GoldCH, HellerDA. Health-related quality of life among older adults with arthritis. Health Qual Life Outcomes 2004;2:5.
39. DominickKL, AhernFM, GoldCH, HellerDA. Health-related quality of life and health service use among older adults with osteoarthritis. Arthritis Rheum 2004;51(3):326–31.
40. GallagherRM, VermaS, MosseyJ. Chronic pain. Sources of late-life pain and risk factors for disability. Geriatrics 2000;55(9):40–7.
41. ColeMG, DendukuriN. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003;160(6):1147–56.
42. ChapmanDP, PerryGS. Depression as a major component of public health for older adults. Prev Chronic Dis. 2008;5(1). Available online at: http://www.cdc.gov/pcd/issues/2008/jan/07_0150.htm(accessed 28 March, 2008).
43. LépineJP, BrileyM. The epidemiology of pain in depression. Hum Psychopharmacol 2004;19:S3–7.
44. McCrackenLM, IversonGL. Predicting complaints of impaired cognitive functioning in patients with chronic pain. J Pain Symptom Manage 2001;21(5):392–6.
45. MartinR, WilliamsJ, HadjistavropoulosT, HadjistavropoulosHD, MacLeanM. A qualitative investigation of seniors’ and caregivers’ views on pain assessment and management. Can J Nurs Res 2005;37(2):142–64.
46. PawlickK, MiddaughSJ. Persistent pain in the older patient. In TurkDC, Gatchel RJ, eds. Psychological Approaches to Pain Management: A Practitioner’s Handbook, 2nd ed. New York, NY: Guilford Press; 2002: pp. 553–72.
47. JonesKR, FinkRM, ClarkL, et al. Nursing home resident barriers to effective pain management: why nursing home residents may not seek pain medication. J Am Med Dir Assoc 2005;6(1):10–17.
48. BencaRM. Diagnosis and treatment of chronic insomnia: a review. Psychiatr Serv 2005;56:332–43.
49. KeefeFK, RumbleME, ScipioCD, GiordanoLA, PerriLM. Psychological aspects of persistent pain: current state of the science. J Pain 2004;5(4):195–211.
50. SmithMT, HaythornthwaiteJA. Cognitive-behavioral treatment for insomnia and pain. In LavigneG, SessleBJ, ChoiniereM, SojaPJ, eds. Sleep and Pain. Seattle: IASP Press; 2007: pp. 439–58.
51. CleelandCS, RyanKM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994;23:129–38.
52. MelzackR. The Short-Form McGill Pain Questionnaire. Pain 1987;30:191–7.
53. SpitzerRL, WilliamsJB, KroenkeK, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME MD 1000 study. JAMA 1994;272:1749–56.
54. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 1994.
55. SpitzerRL, KroenkeK, WilliamsJB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282(18):1737–44.
56. SharpLK, LipskyMS. Screening for depression across the lifespan: a review of measures for use in primary care settings. Am Fam Physician 2002;66(6):1001–8.
57. BeckAT. Beck Depression Inventory. Philadelphia, PA: Center for Cognitive Therapy; 1961.
58. BeckAT, SteerRA, BrownGK. BDI-II, Beck Depression Inventory: Manual. 2nd ed. Boston: Harcourt Brace; 1996.
59. BeckAT, GuthD, SteerRA, BallR. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behav Res Ther 1997;35:785–91.
60. YesavageJA, BrinkTL, RoseTL, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982–1983;17(1):37–49.
61. Bolla-WilsonK, BleeckerML. Absence of depression in elderly adults. J Gerontol 1989;44(2):P53–5.
62. SpielmanAJ, CarusoLS, GlovinskyPB. A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 1987;10(4):541–53.
63. SmithMT, PerlisML, ParkA, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002;159(1):5–11.
64. CurrieSR, WilsonKG, PontefractAJ, deLaplanteL. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psychol 2000;68(3):407–16.
65. CurrieSR, WilsonKG, CurranD. Clinical significance and predictors of treatment response to cognitive-behavior therapy for insomnia secondary to chronic pain. J Behav Med 2002;25(2):135–53.
66. MorinCM, KowatchRA, WadeJB. Behavioral management of sleep disturbances secondary to chronic pain. J Behav Ther Exp Psychiatry 1989;20(4):295–302.
67. LichsteinKL, WilsonNM, JohnsonCT. Psychological treatment of secondary insomnia. Psychol Aging 2000;15(2):232–40.
68. HaythornthwaiteJA, Hegel, MT, KernsRD. Development of a sleep diary for chronic pain patients. J Pain Symptom Manag 1991;6:65–72.
69. LichsteinKL, RiedelBW, WilsonNM, LesterKW, AguillardRN. Relaxation and sleep compression for late-life insomnia: a placebo controlled trial. JCCP 2001;69(2):227–39.
70. FickDM, CooperJW, WadeWE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US Consensus Panel of Experts. Arch Intern Med 2003;162:2716–24.
71. BeaulieuP, WalczakJ-S. Pharmacological management of sleep and pain interactions. In LavigneG, SessleBJ, ChoiniereM, SojaPJ, eds. Sleep and Pain. Seattle: IASP Press; 2007: pp. 391–416.

References

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR), 4th ed. Washington, DC: American Psychiatric Association; 2000.
2. KesslerRC, BerglundP, DemlerO, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62:593–602.
3. BeekmanAT, BremmerMA, DeegDJ, et al. Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatric Psychiatry 1998;13:717–26.
4. de BeursE, Beekman, A, GeerlingsS, et al. On becoming depressed or anxious in late life: similar vulnerability factors but different effects of stressful life events. British Journal of Psychiatry: The Journal of Mental Science 2001;179:426–31.
5. LenzeEJ, MulsantBH, MohlmanJ, et al. Generalized anxiety disorder in late life: lifetime course and comorbidity with major depressive disorder. Am J Geriatr Psychiatry 2005;13:77–80.
6. de BeursE, BeekmanAT, van BalkomAL, et al. Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychol Med 1999;29:583–93.
7. OhayonMM, CauletM, LemoineP. Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry 1998;39:185–97.
8. MontiJM, MontiD. Sleep disturbance in generalized anxiety disorder and its treatment. Sleep Med Rev 2000;4:263–76.
9. FullerKH, WatersWF, BinksPG, AndersonT. Generalized anxiety and sleep architecture: a polysomnographic investigation. Sleep 1997;20:370–6.
10. SaletuB, Saletu-ZyhlarzG, AndererP, et al. Nonorganic insomnia in generalized anxiety disorder. Neuropsychobiology 1997;36:130–52.
11. BourdetC, GoldenbergF. Insomnia in anxiety: sleep EEG changes. J Psychosomat Res 1994;38(Suppl. 1):93–104.
12. PapadimitriouGN, KerkhofsM, KempenaersC, MendlewiczJ. EEG sleep studies in patients with generalized anxiety disorder. Psychiatry Res 1988;26:183–90.
13. RosaRR, BonnetMH, KramerM. The relationship of sleep and anxiety in anxious subjects. Biol Psychol 1983;16:119–26.
14. SpiraAP, FriedmanL, AulakhJS, et al. Subclinical anxiety symptoms, sleep, and daytime dysfunction in older adults with primary insomnia. J Geriatr Psychiatry Neurol 2008;21:56–60.
15. PapadimitriouGN, LinkowskiP, KerkhofsM, KempenaersC, MendlewiczJ. Sleep EEG recordings in generalized anxiety disorder with significant depression. J Affect Disord 1988;15:113–8.
16. ReynoldsCF, ShawDH, NewtonTF, CoblePA, KupferDJ. EEG sleep in outpatients with generalized anxiety: a preliminary comparison with depressed outpatients. Psychiatry Res 1983;8:81–9.
17. ArriagaF, PaivaT. Clinical and EEG sleep changes in primary dysthymia and generalized anxiety: a comparison with normal controls. Neuropsychobiology 1990;24:109–14.
18. CornaLM, CairneyJ, HerrmannN, et al. Panic disorder in later life: results from a national survey of Canadians. Int Psychogeriatrics 2007;19:1084–96.
19. FlintAJ, GagnonN. Diagnosis and management of panic disorder in older patients. Drugs Aging 2003;20:881–91.
20. RajBA, CorveaMH, DagonEM. The clinical characteristics of panic disorder in the elderly: a retrospective study. J Clin Psychiatry 1993;54:150–5.
21. CairneyJ, CornaLM, VeldbuizenS, HerrmannN, Streimer DL. Comorbid depression and anxiety in later life: patterns of association, subjective well-being, and impairment. Am J Geriatric Psychiatry 2008;16(3):201–8.
22. O’MahonyJF, WardBG. Differences between those who panic by day and those who also panic by night. J Behav Ther Exp Psychiatry 2003;34:239–49.
23. CraskeMG, BarlowDH. Nocturnal panic. J Nervous Mental Dis 1989;177:160–7.
24. KrystalJH, WoodsSW, HillCL, CharneyDS. Characteristics of panic attack subtypes: assessment of spontaneous panic, situational panic, sleep panic, and limited symptom attacks. Compr Psychiatry 1991;32:474–80.
25. MellmanTA, UhdeTW. Sleep panic attacks: new clinical findings and theoretical implications. Am J Psychiatry 1989;146:1204–7.
26. SteinMB, ChartierM, WalkerJR. Sleep in nondepressed patients with panic disorder: I. Systematic assessment of subjective sleep quality and sleep disturbance. Sleep 1993;16:724–6.
27. ArriagaF, PaivaT, Matos-PiresA, et al. The sleep of non-depressed patients with panic disorder: a comparison with normal controls. Acta Psychiatrica Scand 1996;93:191–4.
28. MellmanTA, UhdeTW. Electroencephalographic sleep in panic disorder: a focus on sleep-related panic attacks. Arch Gen Psychiatry 1989;46:178–84.
29. HauriPJ, FriedmanM, RavarisCL. Sleep in patients with spontaneous panic attacks. Sleep 1989;12:323–37.
30. LydiardRB, ZealbergJ, LaraiaMT, et al. Electroencephalography during sleep of patients with panic disorder. J Neuropsychiatry 1989;1:372–6.
31. GrunhausL, RabinD, HarelY, et al. Simultaneous panic and depressive disorders: clinical and sleep EEG correlates. Psychiatry Res 1986;17:251–9.
32. BrownTM, UhdeTW. Sleep panic attacks: a micro-movement analysis. Depress Anxiety 2003;18:214–20.
33. OhayonMM. Anxiety disorders: prevalence, comorbidity and outcomes. J Psychiatr Res 2006;40:475–6.
34 KohnR, WestlakeRJ, RasmussenSA, MarslandRT, NormanWH. Clinical features of obsessive-compulsive disorder in elderly patients. Am J Geriatr Psychiatry 1997;5:211–5.
35. InselTR, GillinJC, MooreA, et al. The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry 1982;39:1372–7.
36. VoderholzerU, RiemannD, Huwig-PoppeC, et al. Sleep in obsessive compulsive disorder: polysomnographic studies under baseline conditions and after experimentally induced serotonin deficiency. Eur Arch Psychiatry Clin Neurosci 2007;257:173–82.
37. RobinsonD, WalslebenJ, PollackS, LernerG. Nocturnal polysomnography in obsessive-compulsive disorder. Psychiatry Res 1998;80:257–63.
38. HohagenF, LisS, KriegerS, et al. Sleep EEG of patients with obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 1994;243:273–8.
39. KlugeM, SchusslerP, DreslerM, YassouridisA, SteigerA. Sleep onset REM periods in obsessive compulsive disorder. Psychiatry Res 2007;152:29–35.
40. PapadimitriouGN, LinkowskiP. Sleep disturbance in anxiety disorders. Int Rev Psychiatry 2005;17:229–36.
41. OverbeekT, SchruersK, VermettenE, GriezE. Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect. J Clin Psychiatry 2002;63:1106–12.
42. TukelR, PolatA, OzdemirO, AksutD, TurksoyN. Comorbid conditions in obsessive-compulsive disorder. Compr Psychiatry 2002;43:204–9.
43. ChangC, WuE, ChangI, LinK. Benzodiazepine and risk of hip fractures in older people: a nested case-control study in Taiwan. Am J Geriatric Psychiatry 2008;16:686–92.
44. BenitezC, SmithK, VasileRG, et al. Use of benzodiazepines and selective serotonin reuptake inhibitors in middle-aged and older adults with anxiety disorders. Am J Geriatric Psychiatry 2008;16:513.
45. PollackM, KinrysG, KrystalA, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008;65(5):551–62.
46. ColeMG, McCuskerJ, DufouilC, CiampiA, BelzileE. Short-term stability of diagnoses of major and minor depression in older medical inpatients. Psychosomatics 2007;48:8–45.
47. HolmquistIB, SvenssonB, HoglundP. Perceived anxiety, depression, and sleeping problems in relation to psychotropic drug use among elderly in assisted-living facilities. Eur J Clin Pharmacol 2005;61:215–24.
48. National Institutes of Health. NIH consensus conference: diagnosis and treatment of depression in late life. J Am Med Assoc 1992;268:1018–24.
49. ColeMG, YaffeMJ. Pathway to psychiatric care of the elderly with depression. Int J Geriatr Psychiatry 1996;11:157–61.
50. ColeMG, DendukuriN. Risk factors for depression among elderly community subjects: a systematic review and meta-analysis. Am J Psychiatry 2003;160:1147–56.
51. LynessJM, NiculescuA, XinT, ReynoldsCF, CaineED. The relationship of medical comorbidity to depression in older, primary care patients. Psychosomatics 2006;47:435–9.
52. BuysseDJ. Insomnia, depression and aging: assessing sleep and mood interactions in older adults. Geriatrics 2004;59:47–51.
53. LivingstonG, BlizardB, MannA. Does sleep disturbance predict depression in elderly people: a study in inner London. Br J Gen Pract 1993;43:445–8.
54. MorinCM, GramlingSE. Sleep patterns and aging: comparison of older adults with and without insomnia complaints. Psychol Aging 1989;4:290–4.
55. KatonWJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216–26.
56. WulsinLR, VaillantGE, WellsVE. A systematic review of the mortality of depression. Psychosom Med 1999;61:6–17.
57. SvarstadBL, MountJK. Effects of residents’ depression, sleep, and demand for medication on benzodiazepine use in nursing homes. Psychiatr Serv 2002;53:1159–65.
58. SteinMB, Barret-ConnorE. Quality of life in older adults receiving medications for anxiety, depression, or insomnia: findings from a community based study. Am J Geriatr Psychiatry 2002;10:568–74.
59. KoponenHJ, ViiloK, HakkoH, et al. Rates and previous disease history in old age suicide. Int J Geriatr Psychiatry 2007;22:38–46.
60. RodinJ, McAvayG, TimkoC. A longitudinal study of depressed mood and sleep disturbances in elderly adults. J Gerontol 1988;43:45–53.
61. BazarganM. Self-reported sleep disturbance among African-American elderly: the effects of depression, health status, exercise, and social support. Int J Aging Hum Dev 1996;42:143–60.
62. TranterR, O’DonovanC, ChandaranaP, KennedyS. Prevalence and outcome of partial remission in depression. J Psychiatry Neurosci 2002;27:241–7.
63. NewmanAB, EnrightPL, ManolioTA, HaponikEF, WahlRL. Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the cardiovascular health study. J Am Geriatr Soc 1997;45:1–7.
64. FoleyDJ, VitielloMV, BliwiseDL, et al. Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: findings from the National Sleep Foundation ‘2003 Sleep in America’ Poll. Am J Geriatr Psychiatry 2007;15:344–50.
65. TsunoN, JaussentI, DauvilliersY, et al. Determinants of excessive daytime sleepiness in a French community-dwelling elderly population. J Sleep Res 2007;16:364–71.
66. HaysJC, BlazerDG, FoleyDJ. Risk of napping: excessive daytime sleepiness and mortality in an older community population. J Am Geriatr Soc 1996;44:693–8.
67. BencaRM. Mood disorders. In KrygerMH, RothT, DementWC, eds. Principles and Practice of Sleep Medicine, 4th ed. Philadelphia, PA: Elsevier Saunders; 2005: pp. 1311–26.
68. BencaRM, ObermeyerWH, ThistedRA, GillinJC. Sleep and psychiatric disorders: a meta-analysis. Archiv Gen Psychiatry 1992;49:651–68.
69. ArgyropoulosSV, WilsonSJ. Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatry 2005;17:237–45.
70. ReynoldsCF, KupferDJ, ThaseME, et al. Sleep, gender, and depression: an analysis of gender effects on the electroencephalographic sleep of 302 depressed outpatients. Biol Psychiatry 1990;28:673–84.
71. ArmitageR, HoffmannR, TrivediM, RushAJ. Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res 2000;95:201–13.
72. HoffmannR, HendrickseW, RushAJ, ArmitageR. Slow-wave activity during non-REM sleep in men with schizophrenia and major depressive disorders. Psychiatry Res 2000;95:215–25.
73. ArmitageR, HoffmannR, FitchT, TrivediM, RushAJ. Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects. Sleep 2000;23:607–17.
74. KupferDJ. Sleep research in depressive illness: clinical implications – a tasting menu. Biol Psychiatry 1995;38:391–403[Review].
75. PetersonMJ, BencaRM. Sleep in mood disorders. Psychiatr Clin North Am 2006;29:1009–32.
76. LiscombeMP, HoffmannRF, TrivediMH, et al. Quantitative EEG amplitude across REM sleep periods in depression: preliminary report. J Psychiatry Neurosci 2002;27:40–6.
77. ThaseME, KupferDJ, FasiczkaAJ, et al. Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry 1997;41:964–73.
78. SmithMT, HuangMI, ManberR. Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev 2005;25(5):559–92.
79. ManberR, EdingerJD, GressJL, et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008;31:489–95.
80. Van SchaikA, van MarwijkH, AderH, et al. Interpersonal psychotherapy for elderly patients in primary care. Am J Geriatr Psychiatry 2006;14(9):777–86.
81. National Institutes of Health. State of the Science Conference statement on manifestations and management of chronic insomnia in adults. Sleep 2005;28(9):1049–57.
82. FavaM, McCallWV, KrystalA, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006;59:1052–60.
83. KrystalA, FavaM, RubensR, et al. Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. J Clin Sleep Med 2007;15:48–55.
84. PetersonMJ, BencaRM. Sleep in mood disorders. Sleep Med Clin 2008;3:231–49.
85. FavaM, ThaseME, DeBattistaC, et al. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness. Ann Clin Psychiatry 2007;19:153–9.

References

1. FruchtS, RogersJD, GreenePE, GordonMF, FahnS. Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology 1999;52(9):1908–10.
2. PostumaRB, MontplaisirJ. Potential early markers of Parkinson’s disease in idiopathic rapid-eye-movement sleep behaviour disorder. Lancet Neurol 2006;5(7):552–3.
3. FronczekR, OvereemS, LeeSY, et al. Hypocretin (orexin) loss in Parkinson’s disease. Brain 2007;130(Pt 6):1577–85.
4. TandbergE, LarsenJP, KarlsenK. A community-based study of sleep disorders in patients with Parkinson’s disease. Mov Disord 1998;13(6):895–9.
5. FactorSA, McAlarneyT, Sanchez-RamosJR, WeinerWJ. Sleep disorders and sleep effect in Parkinson’s disease. Mov Disord 1990;5(4):280–5.
6. LeesAJ, BlackburnNA, CampbellVL. The nighttime problems of Parkinson’s disease. Clin Neuropharmacol 1988;11(6):512–19.
7. DhawanV, DhoatS, WilliamsAJ, et al. The range and nature of sleep dysfunction in untreated Parkinson’s disease (PD): a comparative controlled clinical study using the Parkinson’s disease sleep scale and selective polysomnography. J Neurological Sci 2006;248(1–2):158–62.
8. ComellaCL. Sleep disturbances in Parkinson’s disease. Curr Neurol Neurosci Rep 2003;3(2):173–80.
9. GjerstadMD, Wentzel-LarsenT, AarslandD, LarsenJP. Insomnia in Parkinson’s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry 2007;78(5):476–9.
10. AskenasyJJ, YahrMD. Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 1990;53(9):749–53.
11. AskenasyJJ. Sleep in Parkinson’s disease. Acta Neurologica Scandinavica 1993;87(3):167–70.
12. LinazasoroG, Marti MassoJF, SuarezJA. Nocturnal akathisia in Parkinson’s disease: treatment with clozapine. Mov Disord 1993;8(2):171–4.
13. van HiltenB, HoffJI, MiddelkoopHA, et al. Sleep disruption in Parkinson’s disease: assessment by continuous activity monitoring. Arch Neurol 1994;51(9):922–8.
14. StackEL, AshburnAM. Impaired bed mobility and disordered sleep in Parkinson’s disease. Mov Disord 2006;21(9):1340–2.
15. LeesAJ. A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson’s disease. Eur Neurol 1987;27(Suppl. 1):126–34.
16. PrianoL, AlbaniG, BrioschiA, et al. Nocturnal anomalous movement reduction and sleep microstructure analysis in parkinsonian patients during 1-night transdermal apomorphine treatment. Neurol Sci 2003;24(3):207–8.
17. RomigiA, StanzioneP, MarcianiMG, et al. Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson’s disease: an open label 24-hour polysomnographic study. J Neural Transm 2006;113(12):1909–13.
18. ComellaCL, MorrisseyM, JankoK. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology 2005;64(8):1450–1.
19. NausiedaPA, GlantzR, WeberS, BaumR, KlawansHL. Psychiatric complications of levodopa therapy of Parkinson’s disease. Adv Neurol 1984;40:271–7.
20. GrandasF, IranzoA. Nocturnal problems occurring in Parkinson’s disease. Neurology 2004;63(8 Suppl. 3):S8–11.
21. Gomez-EstebanJC, ZarranzJJ, LezcanoE, et al. Sleep complaints and their relation with drug treatment in patients suffering from Parkinson’s disease. Mov Disord 2006;21(7):983–8.
22. SchenckCH, BundlieSR, EttingerMG, MahowaldMW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 2002;25(2):293–308.
23. SchenckCH, HurwitzTD, MahowaldMW. REM sleep behavior disorder. Am J Psychiatry 1988;145(5):652.
24. BoeveBF, SilberMH, ParisiJE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;61(1):40–5.
25. GagnonJF, PostumaRB, MazzaS, DoyonJ, MontplaisirJ. Rapid-eye-movement sleep behaviour disorder and neurodegenerative diseases. Lancet Neurol 2006;5(5):424–32.
26. IranzoA, SchenckCH, FonteJ. REM sleep behavior disorder and other sleep disturbances in Disney animated films. Sleep Med 2007;8(5):531–6.
27. PlazziG, CorsiniR, ProviniF, et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997;48(4):1094–7.
28. VetrugnoR, ProviniF, CortelliP, et al. Sleep disorders in multiple system atrophy: a correlative video-polysomnographic study. Sleep Med 2004;5(1):21–30.
29. ComellaCL, NardineTM, DiederichNJ, StebbinsGT. Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson’s disease. Neurology 1998;51(2):526–9.
30. GagnonJF, BedardMA, FantiniML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson’s disease. Neurology 2002;59(4):585–9.
31. ScaglioneC, VignatelliL, PlazziG, et al. REM sleep behaviour disorder in Parkinson’s disease: a questionnaire-based study. Neurol Sci 2005;25(6):316–21.
32. OzekmekciS, ApaydinH, KilicE. Clinical features of 35 patients with Parkinson’s disease displaying REM behavior disorder. Clin Neurol Neurosurg 2005;107(4):306–9.
33. SchenckCH, BundlieSR, MahowaldMW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46(2):388–93.
34. OlsonEJ, BoeveBF, SilberMH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123(Pt 2):331–9.
35. IranzoA, MolinuevoJL, SantamariaJ, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006;5(7):572–7.
36. Fantini, ML, Ferini-StrambiL, MontplaisirJ. Idiopathic REM sleep behavior disorder: toward a better nosologic definition. Neurology 2005;64(5):780–6.
37. BoeveBF, SilberMH, SaperCB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007;130:2770–88.
38. BraakH, Del TrediciK, RubU, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 2003;24(2):197–211.
39. EisensehrI, LinkeR, NoachtarS, et al. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder: comparison with Parkinson’s disease and controls. Brain 2000;123(Pt 6):1155–60.
40. EisensehrI, LinkeR, TatschK, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters: IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson’s disease, and controls. Sleep 2003;26(5):507–12.
41. De CockVC, VidailhetM, LeuS, et al. Restoration of normal motor control in Parkinson’s disease during REM sleep. Brain 2007;130(Pt 2):450–6.
42. BoeveBF, SaperCB. REM sleep behavior disorder: a possible early marker for synucleinopathies. Neurology 2006;66(6):796–7.
43. PacchettiC, ManniR, ZangagliaR, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 2005;20(11):1439–48.
44. ArnulfI, BonnetAM, DamierP, et al. Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology 2000;55(2):281–8.
45. SinforianiE, ZangagliaR, ManniR, et al. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson’s disease. Mov Disord 2006;21(4):462–6.
46. SchenckCH, MahowaldMW. Rapid eye movement sleep parasomnias. Neurol Clin 2005;23(4):1107–26.
47. FantiniML, GagnonJF, FilipiniD, MontplaisirJ. The effects of pramipexole in REM sleep behavior disorder. Neurology 2003;61(10):1418–20.
48. RingmanJM, SimmonsJH. Treatment of REM sleep behavior disorder with donepezil: a report of three cases. Neurology 2000;55(6):870–1.
49. BoeveBF, SilberMH, FermanTJ. Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients. Sleep Med 2003;4(4):281–4.
50. StriederDJ, BakerWG, BaringerJR, KazemiH. Chronic hypoventilation of central origin: a case with encephalitis lethargica and Parkinson’s syndrome. Am Rev Resp Dis 1967;96(3):501–7.
51. WetterTC, Collado-SeidelV, PollmacherT, YassouridisA, TrenkwalderC. Sleep and periodic leg movement patterns in drug-free patients with Parkinson’s disease and multiple system atrophy. Sleep 2000;23(3):361–7.
52. ArnulfI, KonofalE, Merino-AndreuM, et al. Parkinson’s disease and sleepiness: an integral part of PD. Neurology 2002;58(7):1019–24.
53. DiederichNJ, VaillantM, LeischenM, et al. Sleep apnea syndrome in Parkinson’s disease: a case-control study in 49 patients. Mov Disord 2005;20(11):1413–8.
54. YoungA, HomeM, ChurchwardT, et al. Comparison of sleep disturbance in mild versus severe Parkinson’s disease. Sleep 2002;25(5):573–7.
55. MariaB, SophiaS, MichalisM, et al. Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 2003;97(10):1151–7.
56. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime sleepiness in de novo and treated Parkinson’s disease. Mov Disord 2002;17(5):1026–30.
57. RyeDB. Excessive daytime sleepiness and unintended sleep in Parkinson’s disease. Curr Neurol Neurosci Rep 2006;6(2):169–76.
58. ChaudhuriKR. The basis for day and night-time control of symptoms of Parkinson’s disease. Eur J Neurol 2002;9(Suppl 3):40–3.
59. PoeweW, HoglB. Akathisia, restless legs and periodic limb movements in sleep in Parkinson’s disease. Neurology 2004;63(8 Suppl. 3):S12–16.
60. OndoWG, HeY, RajasekaranS, LeWD. Clinical correlates of 6-hydroxydopamine injections into A11 dopaminergic neurons in rats: a possible model for restless legs syndrome. Mov Disord 2000;15(1):154–8.
61. PittockSJ, ParrettT, AdlerCH, et al. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Mov Disord 2000;19(6):695–9.
62. WetterTC, EisensehrI, TrenkwalderC. Functional neuroimaging studies in restless legs syndrome. Sleep Med 2000;5(4):401–6.
63. LinkeR, EisensehrI, WetterTC, et al. Presynaptic dopaminergic function in patients with restless legs syndrome: are there common features with early Parkinson’s disease?Mov Disord 2004;19(10):1158–62.
64. NomuraT, InoueY, MiyakeM, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord 2006;21(3):380–4.
65. Braga-NetoP, da Silva-JuniorFP, Sueli MonteF, de BruinPF, de BruinVM. Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci 2004;217(1):41–5.
66. Driver-DunckleyE, EvidenteVG, AdlerCH, et al. Restless legs syndrome in Parkinson’s disease patients may improve with subthalamic stimulation. Mov Disord 2006;21(8);1287–9.
67. KediaS, MoroE, TagliatiM, LangAE, KumarR. Emergence of restless legs syndrome during subthalamic stimulation for Parkinson disease. Neurology 2004;63(12):2410–2.
68. BordetR, DevosD, BriqueS, et al. Study of circadian melatonin secretion pattern at different stages of Parkinson’s disease. Clin Neuropharmacol 2003;26(2):65–72.
69. FertlE, AuffE, DoppelbauerA, WaldhauserF. Circadian secretion pattern of melatonin in Parkinson’s disease. J Neural Transm Park Dis Dement Sect 1991;3(1):41–7.
70. FertlE, AuffE, DoppelbauerA, WaldhauserFCircadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J Neural Transm Park Dis Dement Sect 1993;5(3):227–34.
71. PausS, Schmitz-HubschT, WullnerU, et al. Bright light therapy in Parkinson’s disease: a pilot study. Mov Disord 2007;22(10):1495–8.
72. WillisGL, TurnerEJ. Primary and secondary features of Parkinson’s disease improve with strategic exposure to bright light: a case series study. Chronobiol Int 2007;24(3):521–37.
73. ShpirerI, MiniovitzA, KleinC, et al. Excessive daytime sleepiness in patients with Parkinson’s disease: a polysomnography study. Mov Disord 2006;21(9):1432–8.
74. TandbergE, LarsenJP, KarlsenK. Excessive daytime sleepiness and sleep benefit in Parkinson’s disease: a community-based study. Mov Disord 1999;14(6):922–7.
75. OndoWG, Dat VuongK, KhanH, et al. Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology 2001;57(8):1392–6.
76. PalS, BhattacharyaKF, AgapitoC, ChaudhuriKR. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson’s disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy. J Neural Transm 2001;108(1):71–7.
77. BarbarSI, EnrightPL, BoyleP, et al. Sleep disturbances and their correlates in elderly Japanese American men residing in Hawaii. The Journals of Gerontology 2000;55(7):M406–11.
78. FurumotoH. Excessive daytime somnolence in Japanese patients with Parkinson’s disease. Eur J Neurol 2004;11(8):535–40.
79. PausS, BrechtHM, KosterJ, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson’s disease. Mov Disord 2003;18(6):659–67.
80. KornerY, MeindorfnerC, MollerJC, et al. Predictors of sudden onset of sleep in Parkinson’s disease. Mov Disord 2004;19(11):1298–305.
81. HobsonDE, LangAE, MartinWR, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002;287(4):455–63.
82. MeindorfnerC, KornerY, MollerJC, et al. Driving in Parkinson’s disease: mobility, accidents, and sudden onset of sleep at the wheel. Mov Disord 2005;20(7):832–42.
83. AbbottA. Neuroscience: the molecular wake-up call. Nature 2007;447(7143):368–70.
84. RyeDB, BliwiseDL, DiheniaB, GureckiP. FastTRACK: daytime sleepiness in Parkinson’s disease. J Sleep Res 2000;9(1):63–9.
85. KumarS, BhatiaM, BehariM. Excessive daytime sleepiness in Parkinson’s disease as assessed by Epworth Sleepiness Scale (ESS). Sleep Med 2003;4(4):339–42.
86. LuJ, ShermanD, DevorM, SaperCB. A putative flip-flop switch for control of REM sleep. Nature 2006;441(7093):589–94.
87. DrouotX, MoutereauS, NguyenJP, et al. Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology 2003;61(4):540–3.
88. OvereemS, van HiltenJJ, RipleyB, et al. Normal hypocretin-1 levels in Parkinson’s disease patients with excessive daytime sleepiness. Neurology 2002;58(3):498–9.
89. FrauscherB, HoglB, MaretS, et al. Association of daytime sleepiness with COMT polymorphism in patients with parkinson disease: a pilot study. Sleep 2004;27(4):733–6.
90. RisslingI, KornerY, GellerF, et al. Preprohypocretin polymorphisms in Parkinson disease patients reporting “sleep attacks”. Sleep 2005;28(7):871–5.
91. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime somnolence in Parkinson’s disease: follow-up after 1 year of treatment. Neurol Sci 2003;24(3):178–9.
92. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: a randomized controlled trial. Jama 2000;284(15):1931–8.
93. RascolO, BrooksDJ, KorczynAD, et al. A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa – 056 Study Group. New Engl J Med 2000;342(20):1484–91.
94. LesserRP, FahnS, SniderSR, et al. Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 1979;29(9 Pt 1):1253–60.
95. SchlesingerI, RavinPD. Dopamine agonists induce episodes of irresistible daytime sleepiness. Eur Neurol 2003;49(1):30–3.
96. GhorayebI, LoundouA, AuquierP, et al. A nationwide survey of excessive daytime sleepiness in Parkinson’s disease in France. Mov Disord 2007;22(11):1567–72.
97. OndoWG, VuongKD, JankovicJ. Exploring the relationship between Parkinson disease and restless legs syndrome. Arch Neurol 2002;59(3):421–4.
98. OlanowCW, SchapiraAH, RothT. Waking up to sleep episodes in Parkinson’s disease. Mov Disord 2000;15(2):212–5.
99. BrodskyMA, GodboldJ, RothT, OlanowCW. Sleepiness in Parkinson’s disease: a controlled study. Mov Disord 2003;18(6):668–72.
100. ChaudhuriKR, PalS, DiMarcoA, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002;73(6):629–35.
101. MarinusJ, VisserM, van HiltenJJ, LammersGJ, StiggelboutAM. Assessment of sleep and sleepiness in Parkinson disease. Sleep 2003;26(8):1049–54.
102. AdlerCH, CavinessJN, HentzJG, LindM, TiedeJ. Randomized trial of modafinil for treating subjective daytime sleepiness in patients with Parkinson’s disease. Mov Disord 2003;18(3):87–293.
103. HoglB, SaletuM, BrandauerE, et al. Modafinil for the treatment of daytime sleepiness in Parkinson’s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 2002;25(8):905–9.
104. OndoWG, FayleR, AtassiF, JankovicJ. Modafinil for daytime somnolence in Parkinson’s disease: double blind, placebo controlled parallel trial. J Neurol Neurosurg Psychiatry 2005;76(12):1636–9.
105. NievesAV, LangAE. Treatment of excessive daytime sleepiness in patients with Parkinson’s disease with modafinil. Clin Neuropharmacol 2002;25(2):111–4.
106. DowlingGA, MastickJ, CollingE, et al. Melatonin for sleep disturbances in Parkinson’s disease. Sleep Med 2005;6(5):459–66.
107. AntoniniA, LandiA, MarianiC, DeNotarisR, PezzoliG. Deep brain stimulation and its effect on sleep in Parkinson’s disease. Sleep Med 2004;5(2):211–4.
108. HjortN, OstergaardK, DupontE. Improvement of sleep quality in patients with advanced Parkinson’s disease treated with deep brain stimulation of the subthalamic nucleus. Mov Disord 2004;19(2):196–9.
109. PacchettiC, ManniR, ZangagliaR, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson’s disease. Mov Disord 2005;20(11):1439–48.
110. KumruH, SantamariaJ, TolosaE, et al. Rapid eye movement sleep behavior disorder in parkinsonism with parkin mutations. Annals of Neurology 2004;56(4):599–603.
111. DiederichNJ, VaillantM, LeischenM, et al. Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord 2005;20(11):1413–18.
112. Ferini-StrambiL, FranceschiM, PintoP, ZucconiM, SmirneS. Respiration and heart rate variability during sleep in untreated Parkinson patients. Gerontology 1992;38(1-2):92–8.
113. EfthimiouJ, EllisSJ, HardieRJ, SternGM. Sleep apnea in idiopathic and postencephalitic parkinsonism. Advances in Neurology 1987;45:275–6.
114. AppsMC, SheaffPC, IngramDA, KennardC, EmpeyDW. Respiration and sleep in Parkinson’s disease. J Neurol Neurosurg Psychiatry 1985;48(12):1240–5.
115. Gomez-EstebanJC, ZarranzJJ, TijeroB, et al. Restless legs syndrome in Parkinson’s disease. Mov Disord 2007.
116. KrishnanPR, BhatiaM, BehariM. Restless legs syndrome in Parkinson’s disease: a case-controlled study. Mov Disord 2003;18(2):181–5.
117. KumarS, BhatiaM, BehariM. Sleep disorders in Parkinson’s disease. Mov Disord 2002;17(4):775–81.
118. TanEK, LumSY, WongMC. Restless legs syndrome in Parkinson’s disease. Journal of the Neurological Sciences 2002;196(1-2):33–6.
119. LangAE. Restless legs syndrome and Parkinson’s disease: insights into pathophysiology. Clinical Neuropharmacology 1987;10(5):476–8.
120. MonacaC, DuhamelA, JacquessonJM, et al. Vigilance troubles in Parkinson’s disease: a subjective and objective polysomnographic study. Sleep Medicine 2006;7(5):448–53.
121. GjerstadMD, AlvesG, Wentzel-LarsenT, AarslandD, LarsenJP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?Neurology 2006;67(5):853–8.
122. FerreiraJJ, DesboeufK, GalitzkyM, et al. Sleep disruption, daytime somnolence and ‘sleep attacks’ in Parkinson’s disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol 2006;13(3):209–14.
123. WegelinJ, McNamaraP, DursoR, BrownA, McLarenD. Correlates of excessive daytime sleepiness in Parkinson’s disease. Parkinsonism Relat Disord 2005;11(7):441–8.
124. ManniR, TerzaghiM, SartoriI, ManciniF, PacchettiC. Dopamine agonists and sleepiness in PD: review of the literature and personal findings. Sleep Medicine 2004;5(2):189–93.
125. RazmyA, LangAE, ShapiroCM. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Archives of Neurology 2004;61(1):97–102.
126. HoglB, SeppiK, BrandauerE, et al. Increased daytime sleepiness in Parkinson’s disease: a questionnaire survey. Mov Disord 2003;18(3):319–23.
127. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime somnolence in Parkinson’s disease. Follow-up after 1 year of treatment. Neurol Sci 2003;24(3):178–9.
128. Merino-AndreuM, ArnulfI, KonofalE, DerenneJP, AgidY. Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness. Neurology 2003;60(9):1553–4.
129. FabbriniG, BarbantiP, AuriliaC, et al. Excessive daytime sleepiness in de novo and treated Parkinson’s disease. Mov Disord 2002;17(5):1026–30.
130. O’SuilleabhainPE, DeweyRB, Jr. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Archives of Neurology 2002;59(6):986–9.
131. TanEK, LumSY, Fook-ChongSM, et al. Evaluation of somnolence in Parkinson’s disease: comparison with age- and sex-matched controls. Neurology 2002;58(3):465–8.
132. MontastrucJL, Brefel-CourbonC, SenardJM, et al. Sleep attacks and antiparkinsonian drugs: a pilot prospective pharmacoepidemiologic study. Clinical Neuropharmacology 2001;24(3):181–3.

References

1. PollakCP, PerlickD. Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol 1991;4(4):204–10.
2. BraakH, BraakE. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82(4):239–59.
3. YesavageJA, et al. Development of diagnostic criteria for defining sleep disturbance in Alzheimer’s disease. J Geriatr Psychiatry Neurol 2003;16(3):131–9.
4. StickgoldR. Sleep-dependent memory consolidation. Nature 2005;437(7063):1272–8.
5. BorbelyAA. A two process model of sleep regulation. Hum Neurobiol 1982;1(3):195–204.
6. CzeislerCA, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999;284(5423):2177–81.
7. WrightKP Jr, et al. Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans. Proc Natl Acad Sci USA 2001;98(24):14027–32.
8. HullJT, WrightKP Jr, CzeislerCA. The influence of subjective alertness and motivation on human performance independent of circadian and homeostatic regulation. J Biol Rhythms 2003;18(4):329–38.
9. AserinskyE, KleitmanN. Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science 1953;118(3062):273–4.
10. DementW, KleitmanN. Cyclic variations in EEG during sleep and their relation to eye movements, body motility, and dreaming. Electroencephalogr Clin Neurophysiol 1957;9(4):673–90.
11. RechtschaffenA, KalesA. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA; 1968.
12. PatrickGTW, GilbertJA. Studies from the Psychological Laboratory of the University of Iowa. Psychol Rev 1896;3:468–83.
13. DurmerJS, DingesDF. Neurocognitive consequences of sleep deprivation. Semin Neurol 2005;25(1): 117–29.
14. DrummondSP, et al. Sleep deprivation-induced reduction in cortical functional response to serial subtraction. Neuroreport 1999;10(18):3745–8.
15. HarrisonY, HorneJA. Sleep deprivation affects speech. Sleep 1997;20(10):871–7.
16. GlenvilleM, et al. Effects of sleep deprivation on short duration performance measures compared to the Wilkinson auditory vigilance task. Sleep 1978;1(2):169–76.
17. RogersNL, DorrianJ, DingesDF. Sleep, waking and neurobehavioural performance. Front Biosci 2003;8:S1056–67.
18. WilliamsHL, GiesekingCF, LubinA. Some effects of sleep loss on memory. Percept Mot Skills 1966;23(3):1287–93.
19. PolzellaDJ. Effects of sleep deprivation on short-term recognition memory. J Exp Psychol [Hum Learn] 1975;104(2):194–200.
20. DrummondSP, et al. Altered brain response to verbal learning following sleep deprivation. Nature 2000;403(6770):655–7.
21. CarskadonMA, DementWC. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology 1981;18(2):107–13.
22. Van DongenHP, et al. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003;26(2):117–26.
23. BoivinDB, et al. Complex interaction of the sleep-wake cycle and circadian phase modulates mood in healthy subjects. Arch Gen Psychiatry 1997;54(2):145–52.
24. JohnsonMP, et al. Short-term memory, alertness and performance: a reappraisal of their relationship to body temperature. J Sleep Res 1992;1(1):24–9.
25. JewettME, KronauerRE. Interactive mathematical models of subjective alertness and cognitive throughput in humans. J Biol Rhythms 1999;14(6):588–97.
26. MullerGE, PilzeckerA. Expermentelle Beitrage zur Lehre vom Gedachtnis. Z. Psychol. Erganzungsband 1900;1:1–300.
27. ShadmehrR, HolcombHH. Neural correlates of motor memory consolidation. Science 1997;277(5327):821–5.
28. SquireLR, ZolaSM. Structure and function of declarative and nondeclarative memory systems. Proc Natl Acad Sci USA 1996;93(24):13515–22.
29. EichenbaumH. A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 2000;1(1): 41–50.
30. van Halteren-van TilborgIA, ScherderEJ, HulstijnW. Motor-skill learning in Alzheimer’s disease: a review with an eye to the clinical practice. Neuropsychol Rev 2007;17(3):203–12.
31. SmithC. Sleep states and memory processes in humans: procedural versus declarative memory systems. Sleep Med Rev 2001;5(6):491–506.
32. WalkerMP, StickgoldR. Sleep, memory, and plasticity. Annu Rev Psychol 2006;57:139–66.
33. GaisS, et al. Learning-dependent increases in sleep spindle density. J Neurosci 2002;22(15):6830–4.
34. SchabusM, et al. Sleep spindles and their significance for declarative memory consolidation. Sleep 2004;27(8):1479–85.
35. ClemensZ, FaboD, HalaszP. Twenty-four hours retention of visuospatial memory correlates with the number of parietal sleep spindles. Neurosci Lett 2006;403(1–2):52–6.
36. WilsonMA, McNaughtonBL. Reactivation of hippocampal ensemble memories during sleep. Science 1994;265(5172):676–9.
37. SkaggsWE, McNaughtonBL. Replay of neuronal firing sequences in rat hippocampus during sleep following spatial experience. Science 1996;271(5257):1870–3.
38. SiapasAG, WilsonMA. Coordinated interactions between hippocampal ripples and cortical spindles during slow-wave sleep. Neuron 1998;21(5):1123–8.
39. RauchsG, et al. Is there a link between sleep changes and memory in Alzheimer’s disease?Neuroreport 2008;19(11):1159–62.
40. BliwiseDL, et al. Observed sleep/wakefulness and severity of dementia in an Alzheimer’s disease special care unit. J Gerontol A Biol Sci Med Sci 1995;50(6): M303–6.
41. VolicerL, et al. Sundowning and circadian rhythms in Alzheimer’s disease. Am J Psychiatry 2001;158(5): 704–11.
42. HarperDG, et al. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiol Aging 2004;25(6):771–81.
43. BoddyF, et al. Subjectively reported sleep quality and excessive daytime somnolence in Parkinson’s disease with and without dementia, dementia with Lewy bodies and Alzheimer’s disease. Int J Geriatr Psychiatry 2007;22(6):529–35.
44. FeinbergI, KoreskoRL, HellerN. EEG sleep patterns as a function of normal and pathological aging in man. J Psychiatr Res 1967;5(2):107–44.
45. LoewensteinRJ, et al. Disturbances of sleep and cognitive functioning in patients with dementia. Neurobiol Aging 1982;3(4):371–7.
46. PrinzPN, et al. Sleep, EEG and mental function changes in senile dementia of the Alzheimer’s type. Neurobiol Aging 1982;3(4):361–70.
47. ReynoldsCFD, et al. EEG sleep in elderly depressed, demented, and healthy subjects. Biol Psychiatry 1985;20(4):431–42.
48. BliwiseDL, et al. REM latency in Alzheimer’s disease. Biol Psychiatry 1989;25(3):320–8.
49. VitielloMV, et al. Rapid eye movement sleep measures of Alzheimer’s-type dementia patients and optimally healthy aged individuals. Biol Psychiatry 1984;19(5):721–34.
50. ReynoldsCF, 3rd, et al. Sleep apnea in Alzheimer’s dementia: correlation with mental deterioration. J Clin Psychiatry 1985;46(7):257–61.
51. Ancoli-IsraelS, et al. Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc 1991;39(3):258–63.
52. HochCC, et al. Sleep-disordered breathing in normal and pathologic aging. J Clin Psychiatry 1986;47(10):499–503.
53. GehrmanPR, et al. Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. Am J Geriatr Psychiatry 2003;11(4):426–33.
54. YoungT, PeppardPE, GottliebDJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165(9):1217–39.
55. CookeJR, et al. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer’s disease. Behav Sleep Med 2006;4(4): 219–27.
56. Ancoli-IsraelS, et al. Use of wrist activity for monitoring sleep/wake in demented nursing-home patients. Sleep 1997;20(1):24–7.
57. MillsJN, MinorsDS, WaterhouseJM. Adaptation to abrupt time shifts of the oscillator(s) controlling human circadian rhythms. J Physiol (Lond) 1978;285(5):455–70.
58. MinorsDS, WaterhouseJM. The use of constant routines in unmasking the endogenous component of human circadian rhythms. Chronobiol Int 1984;1(3):205–16.
59. DuffyJF, DijkDJ. Getting through to circadian oscillators: why use constant routines?J Biol Rhythms 2002;17(1):4–13.
60. LewyAJ, SackRL. The dim light melatonin onset as a marker for circadian phase position. Chronobiol Int 1989;6(1):93–102.
61. MishimaK, et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biol Psychiatry 1999;45(4):417–21.
62. WuYH, et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J Clin Endocrinol Metab 2003;88(12):5898–906.
63. WittingW, et al. Alterations in the circadian rest-activity rhythm in aging and Alzheimer’s disease. Biol Psychiatry 1990;27(6):563–72.
64. SatlinA, et al. Circadian locomotor activity and core-body temperature rhythms in Alzheimer’s disease. Neurobiol Aging 1995;16(5):765–71.
65. van SomerenEJ, et al. Circadian rest-activity rhythm disturbances in Alzheimer’s disease. Biol Psychiatry 1996;40(4):259–70.
66. HatfieldCF, et al. Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer’s dementia. Brain 2004;127(Pt 5):1061–74.
67. Carvalho-BosSS, et al. Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry 2007;15(2): 92–100.
68. HarperDG, et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry 2001;58(4):353–360.
69. Ancoli-IsraelS, et al. Variations in circadian rhythms of activity, sleep, and light exposure related to dementia in nursing-home patients. Sleep 1997;20(1):18–23.
70. GehrmanP, et al. The timing of activity rhythms in patients with dementia is related to survival. J Gerontol A Biol Sci Med Sci 2004;59(10):1050–5.
71. MooreRY, EichlerVB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 1972;42(1):201–6.
72. StephanFK, ZuckerI. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci USA 1972;69(6):1583–6.
73. HarperDG, et al. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry 2005;46(3):359–68.
74. CarskadonMA, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9(4):519–24.
75. BonanniE, et al. Daytime sleepiness in mild and moderate Alzheimer’s disease and its relationship with cognitive impairment. J Sleep Res 2005;14(3): 311–17.
76. CampbellSS, et al. Exposure to light in healthy elderly subjects and Alzheimer’s patients. Physiol Behav 1988;42(2):141–4.
77. MishimaK, et al. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 1994;89(1):1–7.
78. MishimaK, HishikawaY, OkawaM. Randomized, dim light controlled, crossover test of morning bright light therapy for rest-activity rhythm disorders in patients with vascular dementia and dementia of Alzheimer’s type. Chronobiol Int 1998;15(6): 647–54.
79. Van SomerenEJ, et al. Indirect bright light improves circadian rest-activity rhythm disturbances in demented patients. Biol Psychiatry 1997;41(9): 955–63.
80. Ancoli-IsraelS, et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patients. Behav Sleep Med 2003;1(1):22–36.
81. DowlingGA, et al. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer’s disease. Int Psychogeriatr 2005;17(2):221–36.
82. SloanePD, et al. High-intensity environmental light in dementia: effect on sleep and activity. J Am Geriatr Soc 2007;55(10):1524–33.
83. HickmanSE, et al. The effect of ambient bright light therapy on depressive symptoms in persons with dementia. J Am Geriatr Soc 2007;55(11): 1817–24.
84. Ancoli-IsraelS, et al. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. Am J Geriatr Psychiatry 2003;11(2): 194–203.
85. SkjerveA, et al. Improvement in behavioral symptoms and advance of activity acrophase after short-term bright light treatment in severe dementia. Psychiatry Clin Neurosci 2004;58(4):343–7.
86. Jean-LouisG, von GizyckiH, ZiziF. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 1998;25(3): 177–83.
87. CardinaliDP, et al. The use of melatonin in Alzheimer’s disease. Neuro Endocrinol Lett 2002;23(Suppl. 1):20–3.
88. AsayamaK, et al. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J Nippon Med Sch 2003;70(4):334–41.
89. SingerC, et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 2003;26(7):893–901.
90. DowlingGA, et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s disease. J Am Geriatr Soc 2008;56(2):239–46.
91. Riemersma-van der LekRF, et al